AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$637M |
| 2 |
Pfizer
PFE
|
+$445M |
| 3 |
US Bancorp
USB
|
+$420M |
| 4 |
Synchrony
SYF
|
+$382M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$315M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$569M |
| 2 |
Wells Fargo
WFC
|
+$513M |
| 3 |
AGN
Allergan plc
AGN
|
+$370M |
| 4 |
TWX
Time Warner Inc
TWX
|
+$318M |
| 5 |
HP
HPQ
|
+$318M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.75% |
| 2 | Financials | 15.71% |
| 3 | Technology | 14.9% |
| 4 | Consumer Discretionary | 11.25% |
| 5 | Industrials | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
Spok Holdings
SPOK
$221M
| $531K | ﹤0.01% |
28,983
-360
| -1% | -$6.38K |
|
|
DERM
2427
DELISTED
Dermira, Inc.
DERM
| $530K | ﹤0.01% |
15,300
+6,200
| +68% | +$178K |
|
|
FARO
2428
DELISTED
Faro Technologies
FARO
| $529K | ﹤0.01% |
17,932
-12,471
| -41% | -$393K |
|
|
SGNT
2429
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $529K | ﹤0.01% |
33,230
-2,600
| -7% | -$40.9K |
|
|
AC
2430
DELISTED
Associated Capital Group
AC
| $526K | ﹤0.01% |
+17,341
| New | +$542K |
|
2431
ORIX
IX
$44B
| $526K | ﹤0.01% |
37,415
-8,985
| -19% | -$131K |
|
|
CRC
2432
DELISTED
California Resources Corporation
CRC
| $525K | ﹤0.01% |
22,548
-3,255
| -13% | -$117K |
|
|
APU
2433
DELISTED
AmeriGas Partners, L.P.
APU
| $521K | ﹤0.01% |
15,200
+6,000
| +65% | +$237K |
|
2434
iShares S&P 500 Growth ETF
IVW
$72.5B
| $518K | ﹤0.01% |
17,880
-1,520
| -8% | -$44.2K |
|
2435
Vanda Pharmaceuticals
VNDA
$312M
| $517K | ﹤0.01% |
55,528
| – | – |
|
|
FXCB
2436
DELISTED
FOX CHASE BANCORP INC COM STK (MD)
FXCB
| $517K | ﹤0.01% |
25,490
-62,200
| -71% | -$1.14M |
|
2437
National Beverage
FIZZ
$2.87B
| $516K | ﹤0.01% |
22,700
-1,340
| -6% | -$26K |
|
|
YELL
2438
DELISTED
Yellow Corporation Common Stock
YELL
| $516K | ﹤0.01% |
36,420
+12,400
| +52% | +$195K |
|
2439
Caesars Entertainment
CZR
$6.1B
| $513K | ﹤0.01% |
46,636
| – | – |
|
2440
ANI Pharmaceuticals
ANIP
$1.77B
| $512K | ﹤0.01% |
11,350
| – | – |
|
2441
CVR Energy
CVI
$3.36B
| $512K | ﹤0.01% |
13,000
-740
| -5% | -$31.9K |
|
|
ADPT
2442
DELISTED
Adeptus Health Inc
ADPT
| $511K | ﹤0.01% |
9,380
-1,100
| -10% | -$70.2K |
|
2443
StoneX
SNEX
$8.83B
| $510K | ﹤0.01% |
77,153
+12,657
| +20% | +$80.7K |
|
2444
Sumitomo Mitsui Financial
SMFG
$166B
| $508K | ﹤0.01% |
66,883
-12,659
| -16% | -$99.6K |
|
2445
Central Pacific Financial
CPF
$997M
| $505K | ﹤0.01% |
22,950
+9,850
| +75% | +$218K |
|
2446
Expro Ltd
XPRO
$1.79B
| $504K | ﹤0.01% |
5,036
-508
| -9% | -$51K |
|
|
TTPH
2447
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $503K | ﹤0.01% |
2,507
-150
| -6% | -$29.9K |
|
2448
Theravance Biopharma
TBPH
$874M
| $499K | ﹤0.01% |
30,439
| – | – |
|
|
UTEK
2449
DELISTED
Ultratech Inc.
UTEK
| $499K | ﹤0.01% |
25,164
-8,100
| -24% | -$135K |
|
|
ESPR
2450
DELISTED
Esperion Therapeutics
ESPR
| $498K | ﹤0.01% |
22,370
-1,400
| -6% | -$35.3K |
|
Similar funds
AllianceBernstein's Q4 2015 Portfolio in Review
As of Q4 2015, AllianceBernstein held 3,018 positions worth $118B, up 0.86% from $117B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
AllianceBernstein withdrew a net $5.06B in Q4 2015, closing 101 positions and reducing 1,719 holdings. Its most notable exit was HOMEAWAY INC COM, an estimated $75.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.
Against the trend, AllianceBernstein opened a new position in Alphabet (Google) Class A worth $669M.
- AllianceBernstein's largest Q4 2015 buy was Alphabet (Google) Class A: 17,199,520 shares worth $669M.
- AllianceBernstein added most to Pfizer in Q4 2015, an estimated $445M increase.
- AllianceBernstein's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $569M.
- AllianceBernstein fully exited HOMEAWAY INC COM in Q4 2015, selling an estimated $75.8M.
- AllianceBernstein's ten largest holdings make up 15% of its $118B portfolio in Q4 2015.
- AllianceBernstein opened 79 new positions and closed 101 in Q4 2015.
- AllianceBernstein's portfolio value rose 0.86% quarter-over-quarter to $118B.
Based on AllianceBernstein's 13F filing for Q4 2015, filed 12 Feb 2016.